⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Solventum and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Solventum
↗Saint Paul, Minnesota, USA
Solventum is a global healthcare company that was spun off from 3M on April 1, 2024. The company focuses on developing, manufacturing, and commercializing solutions that leverage material science, data science, and digital capabilities to improve patient outcomes and healthcare efficiency.
Solventum operates across four primary segments: Medical Surgical (wound therapy, surgical supplies, stethoscopes), Dental Solutions (orthodontics, restorative materials), Health Information Systems (software for clinical documentation, coding, and analytics), and Purification & Filtration (biopharmaceutical and industrial filtration). The company is committed to enabling better, smarter, and safer healthcare.
CLASSIFICATION
SIZE & FINANCIALS
Employees:10000+
Revenue:$8B-$9B
Founded:2023
Ownership:public
Status:operating
STOCK
Exchange:NYSE
Ticker:SOLV
Market Cap:$12.2B
PIPELINE
Stage:Commercial
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:3M (Supply agreements and legacy technology transition)
COMPETITION
Position:Leader
Competitors:UnitedHealth Group, Various medical device and healthcare IT companies
LEADERSHIP
Key Executives:
Bryan Hanson - CEO
LINKS
Website:solventum.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Solventum. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.